Seelos Therapeutics, Inc.

MORGAN STANLEY

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/15/2023

Shares

497,380

Value ($000)

92

Weight

0.0%

2020 Q2 - 2023 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/15/2023	92	0.0%	497,380	9/30/2023
2023 Q2	8/14/2023	455	0.0%	380,869	6/30/2023
2023 Q1	5/15/2023	242	0.0%	349,398	3/31/2023
2022 Q4	2/14/2023	239	0.0%	351,335	12/31/2022
2022 Q3	11/14/2022	331	0.0%	321,249	9/30/2022
2022 Q2	10/27/2022	258	0.0%	379,560	6/30/2022
2022 Q1	10/27/2022	309	0.0%	368,777	3/31/2022
2021 Q4	2/14/2022	555	0.0%	340,595	12/31/2021
2021 Q3	11/15/2021	325	0.0%	134,812	9/30/2021
2021 Q2	8/23/2021	2,539	0.0%	961,923	6/30/2021
2021 Q1	5/17/2021	43	0.0%	8,622	3/31/2021
2020 Q4	2/16/2021	6	0.0%	4,000	12/31/2020
2020 Q3	11/13/2020	9	0.0%	10,000	9/30/2020
2020 Q2	8/14/2020	10	0.0%	10,000	6/30/2020